# Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer

> **NCT03410732** · PHASE2 · UNKNOWN · sponsor: **LanZhou University** · enrollment: 120 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **BIOLOGICAL:** activated DCs
- **PROCEDURE:** radical surgery only

## Key facts

- **NCT ID:** NCT03410732
- **Lead sponsor:** LanZhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03410732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03410732, "Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03410732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*